To fully exploit whether temozolomide also acts on tumors in vivo via the LINC00470/EGR2/SOX4 axis, a subcutaneous glioblastoma model was established by injection of U87 cells into nude mice. This evidence concerns the gene EGR2 and glioblastoma.